AAAAAA
Results: 1-25/34
Authors:
Jarvis, B
Markham, A
Citation: B. Jarvis et A. Markham, Inhaled salmeterol - A review of its efficacy in chronic obstructive pulmonary disease, DRUG AGING, 18(6), 2001, pp. 441-472
Authors:
Markham, A
Adkins, JC
Citation: A. Markham et Jc. Adkins, Inhaled salmeterol/fluticasone propionate combination - A pharmacoeconomicreview of its use in the management of asthma, PHARMACOECO, 18(6), 2000, pp. 591-608
Authors:
Spedding, M
Menton, K
Markham, A
Weetman, DF
Citation: M. Spedding et al., Antagonists and the purinergic nerve hypothesis: 2,2 '-pyridylisatogen tosylate (PIT), an allosteric modulator of P2Y receptors. A retrospective on aquarter century of progress, J AUTON NER, 81(1-3), 2000, pp. 225-227
Authors:
Markham, A
Jarvis, B
Citation: A. Markham et B. Jarvis, Inhaled salmeterol/fluticasone propionate combination - A review of its use in persistent asthma, DRUGS, 60(5), 2000, pp. 1207-1233
Authors:
Markham, A
Plosker, GL
Goa, KL
Citation: A. Markham et al., Nicorandil - An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects, DRUGS, 60(4), 2000, pp. 955-974
Authors:
Prakash, A
Markham, A
Citation: A. Prakash et A. Markham, Metoprolol - A review of its use in chronic heart failure, DRUGS, 60(3), 2000, pp. 647-678
Authors:
Markham, A
Lamb, HM
Citation: A. Markham et Hm. Lamb, Infliximab - A review of its use in the management of rheumatoid arthritis, DRUGS, 59(6), 2000, pp. 1341-1359
Authors:
Markham, A
Spencer, CM
Jarvis, B
Citation: A. Markham et al., Irbesartan - An updated review of its use in cardiovascular disorders, DRUGS, 59(5), 2000, pp. 1187-1206
Authors:
Clemett, D
Markham, A
Citation: D. Clemett et A. Markham, Linezolid, DRUGS, 59(4), 2000, pp. 815-827
Authors:
Jarvis, B
Markham, A
Citation: B. Jarvis et A. Markham, Montelukast - A review of its therapeutic potential in persistent asthma, DRUGS, 59(4), 2000, pp. 891-928
Authors:
Clemett, D
Markham, A
Citation: D. Clemett et A. Markham, Prolonged-release mesalazine - A review of its therapeutic potential in ulcerative colitis and Crohn's disease, DRUGS, 59(4), 2000, pp. 929-956
Authors:
Foster, RH
Markham, A
Citation: Rh. Foster et A. Markham, Levobupivacaine - A review of its pharmacology and use as a local anaesthetic, DRUGS, 59(3), 2000, pp. 551-579
Authors:
Clemett, D
Markham, A
Citation: D. Clemett et A. Markham, Azimilide, DRUGS, 59(2), 2000, pp. 271-277
Authors:
Haria, M
Plosker, GL
Markham, A
Citation: M. Haria et al., Felodipine/Metoprolol - A review of the fixed dose controlled release formulation in the management of essential hypertension, DRUGS, 59(1), 2000, pp. 141-157
Authors:
Sorkin, EM
Markham, A
Citation: Em. Sorkin et A. Markham, Cilostazol, DRUG AGING, 14(1), 1999, pp. 63-71
Authors:
Toomes, C
James, J
Wood, AJ
Wu, CL
McCormick, D
Lench, N
Hewitt, C
Moynihan, L
Roberts, E
Woods, CG
Markham, A
Wong, M
Widmer, R
Ghaffar, KA
Pemberton, M
Hussein, IR
Temtamy, SA
Davies, R
Read, AP
Sloan, P
Dixon, MJ
Thakker, NS
Citation: C. Toomes et al., Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis, NAT GENET, 23(4), 1999, pp. 421-424
Authors:
McClellan, KJ
Markham, A
Citation: Kj. Mcclellan et A. Markham, Dofetilide - A review of its use in atrial fibrillation and atrial flutter, DRUGS, 58(6), 1999, pp. 1043-1059
Authors:
Langtry, HD
Markham, A
Citation: Hd. Langtry et A. Markham, Rabeprazole - A review of its use in acid-related gastrointestinal disorders, DRUGS, 58(4), 1999, pp. 725-742
Authors:
Hvizdos, KM
Markham, A
Citation: Km. Hvizdos et A. Markham, Orlistat - A review of its use in the management of obesity, DRUGS, 58(4), 1999, pp. 743-760
Authors:
Langtry, HD
Markham, A
Citation: Hd. Langtry et A. Markham, Fluvastatin: a review of its use in lipid disorders (vol 57, pg 583, 1999), DRUGS, 58(3), 1999, pp. 404-404
Authors:
Simpson, KL
Markham, A
Citation: Kl. Simpson et A. Markham, Ofloxacin otic solution - A review of its use in the management of ear infections, DRUGS, 58(3), 1999, pp. 509-531
Authors:
McClellan, KJ
Markham, A
Citation: Kj. Mcclellan et A. Markham, Perindopril 2mg/indapamide 0.625mg - Fixed low-dose combination, DRUGS, 58(2), 1999, pp. 297-302
Authors:
Prakash, A
Markham, A
Citation: A. Prakash et A. Markham, Long-acting isosorbide monitrate (vol 57, pg 93, 1999), DRUGS, 58(1), 1999, pp. 90-90
Authors:
McClellan, KJ
Wiseman, LR
Markham, A
Citation: Kj. Mcclellan et al., Terbinafine - An update of its use in superficial mycoses, DRUGS, 58(1), 1999, pp. 179-202
Authors:
Langtry, HD
Markham, A
Citation: Hd. Langtry et A. Markham, Sildenafil - A review of its use in erectile dysfunction, DRUGS, 57(6), 1999, pp. 967-989